Literature DB >> 26444136

[Idiopathic Pulmonary Fibrosis].

A Prasse1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia and a disease of the elderly. Cigarette smoking and longterm exposure to substances harming alveolar epithelial cells are risk factors for the development of IPF. There is also evidence for a genetic susceptibility. IPF is defined as the idiopathic variant of Usual Interstitial Pneumonitis (UIP). Diagnosis of IPF is complex and based on the exclusion of other diseases associated with an UIP pattern. The only cure is lung transplantation. In the last years there was a breakthrough in the treatment of IPF. With pirfenidone and nintedanib there are now two compounds approved for the treatment of IPF. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26444136     DOI: 10.1055/s-0034-1393036

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  1 in total

1.  Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.

Authors:  Wencheng Yu; Fang Guo; Xiaoxia Song
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.